---

RMMS Secures Favorable Claim Construction Ruling In Suit Involving Generic Aripiprazole (Abilify®) -

---

RMMS Recognized as Industry Leaders by LMG Life Sciences for Fourth Consecutive Year -

---

RMMS Secures Summary Judgment Against Otsuka Related To Generic Aripiprazole (Abilify®) -

---

Federal Circuit Affirms Judgment of Invalidity Concerning Pulmicort Respules® (budesonide inhalation suspension) -

---

RMMS Secures Second Victory Against Otsuka Related To Generic Aripiprazole (Abilify®) -

---

Chief Judge Simandle Allows Launch of Generic Aripiprazole (Abilify®) -

---

Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions -

---

RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement -

---

RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) -

---

Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets -